BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 12535942)

  • 1. Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2.
    Ozaki S; Narita M; Narita M; Iino M; Miyoshi K; Suzuki T
    Neuroscience; 2003; 116(1):89-97. PubMed ID: 12535942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of extracellular signal-regulated kinase in the ventral tegmental area in the suppression of the morphine-induced rewarding effect in mice with sciatic nerve ligation.
    Ozaki S; Narita M; Narita M; Ozaki M; Khotib J; Suzuki T
    J Neurochem; 2004 Mar; 88(6):1389-97. PubMed ID: 15009639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla.
    Mizoguchi H; Narita M; Wu H; Narita M; Suzuki T; Nagase H; Tseng LF
    Neuroscience; 2000; 100(4):835-9. PubMed ID: 11036217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain.
    Narita M; Suzuki M; Imai S; Narita M; Ozaki S; Kishimoto Y; Oe K; Yajima Y; Yamazaki M; Suzuki T
    Life Sci; 2004 Apr; 74(21):2655-73. PubMed ID: 15041447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacological profiles of morphine and oxycodone under a neuropathic pain-like state in mice: evidence for less sensitivity to morphine.
    Narita M; Nakamura A; Ozaki M; Imai S; Miyoshi K; Suzuki M; Suzuki T
    Neuropsychopharmacology; 2008 Apr; 33(5):1097-112. PubMed ID: 17593930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area.
    Ozaki S; Narita M; Narita M; Iino M; Sugita J; Matsumura Y; Suzuki T
    J Neurochem; 2002 Sep; 82(5):1192-8. PubMed ID: 12358766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a mu-opioid receptor agonist on G-protein activation in streptozotocin-induced diabetic mice.
    Ohsawa M; Mizoguchi H; Narita M; Kamei J; Nagase H; Tseng LF
    Eur J Pharmacol; 2000 Jul; 401(1):55-8. PubMed ID: 10915837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
    Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
    J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mu-opioid receptor gene-dose dependent reductions in G-protein activation in the pons/medulla and antinociception induced by endomorphins in mu-opioid receptor knockout mice.
    Mizoguchi H; Narita M; Oji DE; Suganuma C; Nagase H; Sora I; Uhl GR; Cheng EY; Tseng LF
    Neuroscience; 1999; 94(1):203-7. PubMed ID: 10613510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Region-dependent G-protein activation by mu-, delta 1- and delta 2-opioid receptor agonists in the brain: comparison between the midbrain and forebrain.
    Tsuji M; Narita M; Mizoguchi H; Narita M; Ohsawa M; Kamei J; Nagase H; Takeda H; Matsumiya T; Tseng LF
    Life Sci; 1999; 65(16):PL233-9. PubMed ID: 10573190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the rewarding effects induced by tramadol and its active metabolite M1 after sciatic nerve injury in mice.
    Nakamura A; Narita M; Miyoshi K; Shindo K; Okutsu D; Suzuki M; Higashiyama K; Suzuki T
    Psychopharmacology (Berl); 2008 Oct; 200(3):307-16. PubMed ID: 18758760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional reduction in mu-opioidergic system in the spinal cord under a neuropathic pain-like state following chronic ethanol consumption in the rat.
    Narita M; Miyoshi K; Narita M; Suzuki T
    Neuroscience; 2007 Feb; 144(3):777-82. PubMed ID: 17156932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of spinal protein kinase C in the suppression of morphine-induced rewarding effect under a neuropathic pain-like state in mice.
    Narita M; Oe K; Kato H; Shibasaki M; Narita M; Yajima Y; Yamazaki M; Suzuki T
    Neuroscience; 2004; 125(3):545-51. PubMed ID: 15099668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouse.
    Mizoguchi H; Wu HE; Narita M; Hall FS; Sora I; Uhl GR; Nagase H; Tseng LF
    Neuroscience; 2002; 115(3):715-21. PubMed ID: 12435410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of mu-opioid receptor-mediated G-protein activation in the pons/medulla of mice lacking the exons 2 and 3 of mu-opioid receptor gene.
    Mizoguchi H; Wu HE; Narita M; Loh HH; Nagase H; Tseng LF
    Neurosci Lett; 2002 Dec; 335(2):91-4. PubMed ID: 12459506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of a deletion of protein kinase C gamma isoform in the G-protein activation mediated through opioid receptor-like-1 and mu-opioid receptors in the mouse pons/medulla.
    Narita M; Mizoguchi H; Khotib J; Suzuki M; Ozaki S; Yajima Y; Narita M; Tseng LF; Suzuki T
    Neurosci Lett; 2002 Oct; 331(1):5-8. PubMed ID: 12359310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [(35)S]GTPĪ³S binding and opioid tolerance and efficacy in mouse spinal cord.
    Madia PA; Navani DM; Yoburn BC
    Pharmacol Biochem Behav; 2012 Mar; 101(1):155-65. PubMed ID: 22108651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct evidence for the involvement of endogenous beta-endorphin in the suppression of the morphine-induced rewarding effect under a neuropathic pain-like state.
    Niikura K; Narita M; Narita M; Nakamura A; Okutsu D; Ozeki A; Kurahashi K; Kobayashi Y; Suzuki M; Suzuki T
    Neurosci Lett; 2008 Apr; 435(3):257-62. PubMed ID: 18359165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G protein activation by endomorphins in the mouse periaqueductal gray matter.
    Narita M; Mizoguchi H; Narita M; Dun NJ; Hwang BH; Endoh T; Suzuki T; Nagase H; Suzuki T; Tseng LF
    J Biomed Sci; 2000; 7(3):221-5. PubMed ID: 10810240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.